Pharmaceuticals APAC

APAC Food Allergy Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Food Allergy Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Allergen, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $923.4 Mn Placeholder estimate
Estimate 2025 $1.02 Bn 21.2% of the global market
Projected 2034 $2.60 Bn 153.7% Adds $1.57 Bn over 9 forecast years
CAGR 2025–2034 10.9% Faster than 59% of 180 Pharmaceuticals markets here
Key players 5
  • APAC is 21.16% of the global market.
  • Among regions, the largest is North America at $2.17 Bn.
  • Fastest growing: Africa at 11.3% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.57 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Food Allergy Treatment Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $923.4 Mn — —
2025 (base) $1.02 Bn +$100.6 Mn —
2026 (forecast) $1.14 Bn +$111.6 Mn +10.9%
2027 (forecast) $1.26 Bn +$123.8 Mn +23%
2028 (forecast) $1.40 Bn +$137.3 Mn +36.4%
2029 (forecast) $1.55 Bn +$152.2 Mn +51.3%
2030 (forecast) $1.72 Bn +$168.8 Mn +67.7%
2031 (forecast) $1.90 Bn +$187.2 Mn +86%
2032 (forecast) $2.11 Bn +$207.6 Mn +106.3%
2033 (forecast) $2.34 Bn +$230.3 Mn +128.8%
2034 (forecast) $2.60 Bn +$255.4 Mn +153.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Food Allergy Treatment Market Analysis at a glance
Market size, 2025$1.02 Bn placeholder estimate
Forecast, 2034$2.60 Bn placeholder estimate
Growth (CAGR), 2025–203410.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTreatment, allergen and end user (see all)
Key playersNestle, Genentech Inc., Viatris, ARS Pharmaceuticals, DBV Technologies (see all)
Active clinical trials28 in Asia PacificSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Food Allergy Treatment Market Analysis Executive Summary

Food allergy treatments reduce the risk of serious reactions to foods such as peanuts and milk, and treat reactions when they happen.

Key segments of the food Allergy Treatment market include treatment (Oral Immunotherapy, Biologics and Epinephrine Auto-Injectors) and allergen (Peanut, Milk and Egg).

Bar chart: Asia Pacific Food Allergy Treatment market size, 2024–2034, placeholder estimates. $923.4 Mn in 2024, $1.02 Bn in 2025 and $2.60 Bn in 2034, 10.9% CAGR.
Asia Pacific Food Allergy Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Food Allergy Treatment Market Dynamics

Market Growth Drivers

More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the food Allergy Treatment market. Biosimilars are widening access.

Opportunity

New targets, oral drugs that replace injections and cell therapies for autoimmune disease give the food Allergy Treatment market room to grow.

Market Restraints

High prices, infection risks with immune-suppressing drugs, patent expiries and the need for long-term treatment hold back the food Allergy Treatment market.

Competitive Landscape for Food Allergy Treatment Market in APAC

The food Allergy Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Food Allergy Treatment Market in APAC

Food Allergy Treatment in APAC: rules, payment and research

In some of the countries we cover here, medicines are approved by TGA (Australia)⁠[1], NMPA (China)⁠[2], Drug Office (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], NPRA (Malaysia)⁠[6], Medsafe (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], BPOM (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Drug Administration of Vietnam (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28]. ClinicalTrials.gov lists 28 studies on Food Allergy Treatment that are recruiting, active or about to start in APAC.⁠[29]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Drug Office, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] National Pharmaceutical Regulatory Agency. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] National Agency of Drug and Food Control (BPOM). Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Drug Administration of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

[29] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in APAC. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for food Allergy Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in APAC.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Food Allergy Treatment right now, from free public sources.

Clinical trials

28 active trials in China, India, Japan, South Korea, Australia, Hong Kong, Philippines, Singapore, Thailand, Vietnam, Malaysia, New Zealand, Bangladesh, Afghanistan, Indonesia, Myanmar, Nepal and Pakistan

Recruiting, about to start, or running now. Counted across the 18 countries we report on in APAC.

Top trial sponsors (worldwide)

  1. DBV Technologies 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Longbio Pharma (Suzhou) Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Regeneron Pharmaceuticals 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 42 papers since 2021 (worldwide)

  1. New and Emerging Treatments of Food Allergy. Immunology and allergy clinics of North America, 2026
  2. Biologics in IgE-mediated food allergy: where are we know? Current opinion in allergy and clinical immunology, 2026
  3. 7 for 11: Food allergy treatment therapies. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2026
  4. Safety of a novel oral immunotherapy approach in preschool children with single and multiple food allergies. Frontiers in allergy, 2026
  5. Emerging Allergen Immunotherapy Approaches: Impact on Intradermal and Subcutaneous Strategies in Food Allergy Treatment. Journal of investigational allergology & clinical immunology, 2025
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Food Allergy Treatment in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Food Allergy Treatment market in Asia Pacific?
Placeholder estimate: about $1.02 Bn in 2025, rising to about $2.60 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Food Allergy Treatment market in Asia Pacific growing?
Placeholder estimate: about 10.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Food Allergy Treatment market report cover?
The report splits the market by treatment (Oral Immunotherapy, Biologics, Epinephrine Auto-Injectors, Epinephrine Nasal Spray), allergen (Peanut, Milk, Egg, Tree Nuts) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Food Allergy Treatment market?
Key players include Nestle, Genentech Inc., Viatris, ARS Pharmaceuticals and DBV Technologies.
What is driving the Food Allergy Treatment market?
More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the food Allergy Treatment market. Biosimilars are widening access.
How many clinical trials on Food Allergy Treatment are running in Asia Pacific?
28 studies are recruiting, active or about to start in Asia Pacific, counted across the 18 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Asia Pacific. Retrieved 12 Nov 2026.
How much research is published on Food Allergy Treatment?
PubMed lists 42 papers on Food Allergy Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in APAC

See all

Related on allergies

See the topic